Pharmaceutical composition for thrombin peptide derivatives

Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: HOBSON DAVID W.,CROWTHER ROGER S.,CARNEY DARRELL H.,TANG ANDREW P. K
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HOBSON DAVID W.,CROWTHER ROGER S.,CARNEY DARRELL H.,TANG ANDREW P. K
description Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN1913917A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN1913917A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN1913917A3</originalsourceid><addsrcrecordid>eNrjZLAOyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMz1NIyy9SKMkoys9NysxTKEgtKMlMSVVISS3KLEssySxLLeZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBUBT81JL4p39DC0NjS0NzR2NCasAAGBsL44</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical composition for thrombin peptide derivatives</title><source>esp@cenet</source><creator>HOBSON DAVID W.,CROWTHER ROGER S.,CARNEY DARRELL H.,TANG ANDREW P. K</creator><creatorcontrib>HOBSON DAVID W.,CROWTHER ROGER S.,CARNEY DARRELL H.,TANG ANDREW P. K</creatorcontrib><description>Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070214&amp;DB=EPODOC&amp;CC=CN&amp;NR=1913917A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070214&amp;DB=EPODOC&amp;CC=CN&amp;NR=1913917A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HOBSON DAVID W.,CROWTHER ROGER S.,CARNEY DARRELL H.,TANG ANDREW P. K</creatorcontrib><title>Pharmaceutical composition for thrombin peptide derivatives</title><description>Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAOyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMz1NIyy9SKMkoys9NysxTKEgtKMlMSVVISS3KLEssySxLLeZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBUBT81JL4p39DC0NjS0NzR2NCasAAGBsL44</recordid><startdate>20070214</startdate><enddate>20070214</enddate><creator>HOBSON DAVID W.,CROWTHER ROGER S.,CARNEY DARRELL H.,TANG ANDREW P. K</creator><scope>EVB</scope></search><sort><creationdate>20070214</creationdate><title>Pharmaceutical composition for thrombin peptide derivatives</title><author>HOBSON DAVID W.,CROWTHER ROGER S.,CARNEY DARRELL H.,TANG ANDREW P. K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN1913917A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HOBSON DAVID W.,CROWTHER ROGER S.,CARNEY DARRELL H.,TANG ANDREW P. K</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HOBSON DAVID W.,CROWTHER ROGER S.,CARNEY DARRELL H.,TANG ANDREW P. K</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical composition for thrombin peptide derivatives</title><date>2007-02-14</date><risdate>2007</risdate><abstract>Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_CN1913917A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Pharmaceutical composition for thrombin peptide derivatives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T09%3A15%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HOBSON%20DAVID%20W.,CROWTHER%20ROGER%20S.,CARNEY%20DARRELL%20H.,TANG%20ANDREW%20P.%20K&rft.date=2007-02-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN1913917A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true